Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.01 - $1.36 $130,508 - $175,733
-129,216 Reduced 52.17%
118,459 $130,000
Q1 2024

May 15, 2024

BUY
$0.92 - $1.44 $134,683 - $210,808
146,395 Added 144.54%
247,675 $307,000
Q4 2023

Feb 14, 2024

BUY
$0.64 - $6.49 $5,052 - $51,232
7,894 Added 8.45%
101,280 $106,000
Q3 2023

Nov 14, 2023

SELL
$6.56 - $10.95 $260,103 - $434,167
-39,650 Reduced 29.8%
93,386 $639,000
Q2 2023

Aug 14, 2023

BUY
$7.89 - $10.64 $716,696 - $966,495
90,836 Added 215.25%
133,036 $1.38 Million
Q1 2023

May 15, 2023

BUY
$7.07 - $17.95 $298,354 - $757,490
42,200 New
42,200 $341,000
Q3 2020

Nov 16, 2020

SELL
$1.5 - $2.71 $140,277 - $253,433
-93,518 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$0.75 - $2.18 $901,836 - $2.62 Million
-1,202,448 Reduced 92.78%
93,518 $97,000
Q4 2019

Feb 18, 2020

SELL
$1.02 - $1.97 $2.49 Million - $4.8 Million
-2,438,827 Reduced 65.3%
1,295,966 $2.45 Million
Q3 2019

Nov 14, 2019

BUY
$0.79 - $2.47 $1.32 Million - $4.14 Million
1,676,857 Added 81.48%
3,734,793 $4.03 Million
Q2 2019

Aug 14, 2019

BUY
$2.13 - $7.06 $1.86 Million - $6.16 Million
872,408 Added 73.59%
2,057,936 $4.51 Million
Q1 2019

May 15, 2019

BUY
$5.63 - $7.84 $2.92 Million - $4.07 Million
519,098 Added 77.89%
1,185,528 $7.1 Million
Q4 2018

Feb 14, 2019

BUY
$6.3 - $15.4 $1.66 Million - $4.06 Million
263,806 Added 65.52%
666,430 $4.93 Million
Q3 2018

Nov 14, 2018

BUY
$14.38 - $20.89 $4.62 Million - $6.72 Million
321,458 Added 396.05%
402,624 $5.85 Million
Q2 2018

Aug 14, 2018

BUY
$16.46 - $20.33 $1.34 Million - $1.65 Million
81,166 New
81,166 $1.62 Million

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.